UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036973
Receipt number R000041642
Scientific Title Prospective cohort study of duodenal laparoscopy-endoscopy cooperative surgery for non-ampullary duodenal tumor
Date of disclosure of the study information 2019/06/05
Last modified on 2026/06/09 12:33:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective cohort study of duodenal laparoscopy-endoscopy cooperative surgery for non-ampullary duodenal tumor

Acronym

Prospective study of D-LECS

Scientific Title

Prospective cohort study of duodenal laparoscopy-endoscopy cooperative surgery for non-ampullary duodenal tumor

Scientific Title:Acronym

D-LECS study

Region

Japan


Condition

Condition

superficial non-ampullary duodenal tumor, non-ampullary duodenal submuocsal tumor

Classification by specialty

Hepato-biliary-pancreatic medicine Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Assessment of duodenal laparoscopy-endoscopy cooperative surgery (LECS) for non-ampullary duodenal tumor

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Success rate of treatment

Key secondary outcomes

Adverse event, Treatment time, Hospital stay, Recurrence rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1-1. Superficial non-ampullary duodenal tumor (SNADET) larger than 2cm in size
1-2. SNADET that will not be able to closepost-ESD ulcer
1-3. Duodenal submucosal tumor (SMT) without ulcer larger than 1cm

2. Age older than 20 years

Key exclusion criteria

1. Duodenal tumor that can not be cured with local resection
2. Duodenal ampullary tumor
3. Contraindication for laparoscopic surgery
4. Contraindication for general anethesia, including severe heart and lung failure.
5. A paient without consent
6. Inappropriate case by physician's judgement

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Hiromi
Middle name
Last name Kataoka

Organization

Nagoya City University Hospital

Division name

Department of Gastroenterology

Zip code

467-8601

Address

Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

TEL

052-853-8211

Email

hkataoka@med.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Takaya
Middle name
Last name Shimura

Organization

Nagoya City University Hospital

Division name

Department of Gastroenterology

Zip code

467-8601

Address

Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

TEL

052-853-8211

Homepage URL


Email

tshimura@med.nagoya-cu.ac.jp


Sponsor or person

Institute

Department of Gastroenterology,
Department of Surgery,
Nagoya City University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Management Center, Nagoya City University Hospital

Address

Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya 467-8602, Japan

Tel

052-851-5511

Email

clinical_research@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋市立大学病院


Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 05 Day


Related information

URL releasing protocol

https://www.sciencedirect.com/science/article/pii/S1590865825010746?via%3Dihub

Publication of results

Published


Result

URL related to results and publications

https://www.sciencedirect.com/science/article/pii/S1590865825010746?via%3Dihub

Number of participants that the trial has enrolled

20

Results

The median treatment time was 296 min for total D-LECS and 115 min for ESD. The clinical success rate was 100%, with 100% en bloc resection, 80% R0 resection, and no recurrence.

Results date posted

2026 Year 06 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2025 Year 11 Month 01 Day

Baseline Characteristics

The median tumor size was 30 mm. The tumor locations were as follows: 7 cases in the proximal descending part, 9 cases in the distal descending part, and 4 cases in the transverse part. The breakdown of the postoperative pathological diagnoses for the 20 cases was as follows: VCL Category 3: 6 cases; VCL Category 4/5: 12 cases; NET: 1 case; and lipoma: 1 case.

Participant flow

This study is a single-center, prospective observational study. Between August 2019 and December 2023, 20 patients with superficial nonampullary duodenal tumors located in the descending and horizontal duodenum, in whom endoscopic suturing following ESD was anticipated to be difficult, were prospectively enrolled and underwent D-LECS.

Adverse events

ntraoperative perforations were observed in three cases; however, in all cases, complete closure was promptly achieved via laparoscopic seromuscular suturing following the planned ESD. No cases of postoperative perforation, postoperative bleeding, or postoperative pancreatitis were observed.

Outcome measures

The primary endpoint was clinical success rate, which was 100 %.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 04 Month 19 Day

Date of IRB

2019 Year 06 Month 04 Day

Anticipated trial start date

2019 Year 06 Month 05 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 06 Month 05 Day

Last modified on

2026 Year 06 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041642